EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Scaling cell-based vaccine manufacturing: process redesign achieves an approximately 20-fold increase in relative viral titer

Giovanna Alves de Sousa Dutra, Irana Coletti Malaspina

Vaccine Insights · 06.11.2026 · 5 (9) · 451–458

DOI: 10.18609/vac.2026.055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccine Insights, online erschienen am 06.11.2026. Verfasst von Giovanna Alves de Sousa Dutra und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Scaling adherent viral vaccine processes in roller bottles often increases operational burden in proportion to production capacity, with vessel count, manual handling, and staffing becoming limiting before cell biology does. This article describes a process redesign that combined a new cell line with a consolidated static culture platform, resulting in an approximately 20-fold increase in relative viral titer, a 60% reduction in operators (from five to two), an 86% reduction in units handled (from 400–57), a reduction in processing time from 4.5–1.5 h, and an antibiotic-free process, with animal and serological studies confirming that the final product maintained its expected characteristics and immunological response.

Zitieren

APA

Dutra, G. A. D. S., & Malaspina, I. C. (2026). Scaling cell-based vaccine manufacturing: process redesign achieves an approximately 20-fold increase in relative viral titer. Vaccine Insights, 5(9), 451–458. https://doi.org/10.18609/vac.2026.055

Vancouver

Dutra GADS, Malaspina IC. Scaling cell-based vaccine manufacturing: process redesign achieves an approximately 20-fold increase in relative viral titer. Vaccine Insights. 2026;5(9):451–458. doi:10.18609/vac.2026.055

BibTeX
@article{Dutra2026,
  author = {Dutra, Giovanna Alves de Sousa and Malaspina, Irana Coletti},
  title = {Scaling cell-based vaccine manufacturing: process redesign achieves an approximately 20-fold increase in relative viral titer},
  journal = {Vaccine Insights},
  year = {2026},
  volume = {5},
  number = {9},
  pages = {451–458},
  doi = {10.18609/vac.2026.055}
}
Kostenlos starten →